NXTCL
LIVE

Serial Number

79442092

Owner

NextCell Pharma AB

Filing Date

Dec 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NXTCL Trademark

Serial Number: 79442092

NXTCL is a trademark filed by NextCell Pharma AB on December 8, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

NextCell Pharma AB

Hälsovägen 7

Entity Type: 64

Trademark Details

Filing Date

December 8, 2025

Registration Date

Not Registered

Goods & Services

Science and technology services; research services; scientific research and development; medical and pharmacological research services; laboratory services; analytical laboratory services; scientific services relating to the isolation and cultivation of human tissues and cells; consultancy in the field of scientific research; advisory services relating to scientific research; providing information about industrial analysis and research services; research laboratories; provision of information relating to scientific research; research and development of new products for others; scientific research for medical purposes; laboratory research services relating to pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; clinical trials; culturing of cells for scientific research purposes; stem cell research; quality control and authentication services; providing scientific research information in the field of genetics; providing medical research information in the field of genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about the results of clinical trials for pharmaceutical products; pharmaceutical research services; development of pharmaceutical preparations and medicines; pharmaceutical products development; all of the above services provided exclusively in the fields of biotechnology, pharmaceuticals, regenerative medicine, and stem cell and gene therapy research.

Chemicals used in science; stem cells for research purposes; stem cells for scientific purposes; cell growth media for growing cells for scientific use; biological preparations [other than for medical use]; cultures of cell media [other than for medical or veterinary use].

Live organs and tissues for surgical purposes; pharmaceutical preparations containing stem cells; stem cells for medical purposes; cells for medical use; stem cells; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune diseases; cell growth media for growing cells for medical use.

Filing History

REFUSAL PROCESSED BY IB
May 7, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 22, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 22, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 11, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 10, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 5, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 26, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 26, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 22, 2026 REPR